Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
CA 2804977 A1 · Owner: Signe Biopharma Inc. · Inventors: Sirbasku, David A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Serum-containing and serum-free immunoglobulin inhibitors of steroid hormone responsive , cancer cell growth are disclosed along with their methods of production. Also disclosed are defined cell , culture media assay protocols, and model systems using the inhibitors for demonstrating steroid , hormone growth effects of natural and synthetic substances and other cell , culture applications. The disclosed compositions and methods employing the immunoglobulin inhibitors are also useful as , reagents in research, and for the diagnosis treatment and prevention of mucus , epithelial cancers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 10, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 10, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 10, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.